uses JavaScript to provide the best possible experience for our content, but your browser has it disabled. Learn how to enable it here.


Posted March 14, 2012

Manufacturing Violations by Maker of Lecithin, Soy Supplements

The FDA issued a Warning Letter (dated March 7, 2012) to Modern Products, Inc. regarding manufacturing violations in the production of the supplements Fearn Lecithin Granules, Fearn Liquid Lecithin, Fearn 100% Soy Protein Isolate, and Gayelord Hauser Brewers Yeast.

The FDA noted several violations of Current Good Manufacturing Practice (CGMP) regulations for dietary supplements based on its inspection of the company's facility in Wisconsin, where it receives products that are then repackaged under it own label. The violations include a failure to establish specifications to assure that products it receives to be repackaged for sale are adequately identified; failure to establish and follow written procedures for the responsibilities of the quality control operations; and failure to establish and follow written procedures for packaging and labeling operations.

More details are available using the link below.

For information about protein powders made from soy isolates, see's Product Review of Protein Powders and Drinks.